Antonio Giordano
Molecular Biology · 2006–2019
A researcher in the Science corpus: 5 papers; trusts 5 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 36 citations into it
- Oncology — 29 citations into it; #739 of 1,698 by trust here, #1,352 by citations
- Cell Biology — 16 citations into it; #924 of 2,073 by trust here, #1,656 by citations
- Cancer Research — 6 citations into it
- Pulmonary and Respiratory Medicine — 5 citations into it; #273 of 770 by trust here, #547 by citations
Whom Antonio Giordano trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Antonio Giordano overall
Papers from Antonio Giordano's perspective
Ordered by how strongly the researchers Antonio Giordano trusts endorse each paper. Same corpus, a different order for every researcher.
- Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. (Blood)
- Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice (Nature Genetics)
- Curcumin and cancer: an "old-age" disease with an "age-old" solution. (Cancer Letters)
- Identification of the haematopoietic stem cell niche and control of the niche size (Nature)
- On the road to cancer: aneuploidy and the mitotic checkpoint (Nature Reviews. Cancer)
- ATM and related protein kinases: safeguarding genome integrity (Nature Reviews. Cancer)
- Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. (Cell)
- Microtubules as a target for anticancer drugs (Nature Reviews. Cancer)
- Regulation of chromatin structure by site-specific histone H3 methyltransferases (Nature)
- Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. (The Lancet)
Their papers
- Curcumin and Cancer (2019) — 700 citations
- Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652 (2016) — 1,523 citations
- Cell cycle kinases as therapeutic targets for cancer (2009) — 922 citations
- From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells (2007) — 659 citations
- RB and cell cycle progression (2006) — 1,175 citations